Characterization of nifedipine solid dispersions

The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using a suitable dispenser, appears an interesting approach in the treatment of moderate and severe hypertensive emergencies. With this aim nine S...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 242; no. 1; pp. 313 - 317
Main Authors Cilurzo, F, Minghetti, P, Casiraghi, A, Montanari, L
Format Journal Article Conference Proceeding
LanguageEnglish
Published Amsterdam Elsevier B.V 21.08.2002
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using a suitable dispenser, appears an interesting approach in the treatment of moderate and severe hypertensive emergencies. With this aim nine SD made of NIF and a low viscosity hydroxypropylmethylcellulose (HPMC) in different ratio were prepared by means of spray-drying technique and their structure was studied. Moreover, the drug dissolution properties from SD were verified. The characteristic peaks of crystalline NIF were not detectable by using the X-ray analysis when the NIF/HPMC ratios were lower than 50/50 w/w. In thermograms obtained from SD, the NIF melting endothermic peak disappeared when NIF/HPMC ratios were lower than 30/70 w/w; the experimental Tg values of SD were lower than the Tg values predicted by Gordon Taylor equation suggesting some type of non-ideality of mixing. In the SD FTIR spectra the NH stretching vibrations and the CO stretch in esteric groups of NIF shift to free NH and CO regions indicating the rupture of intermolecular hydrogen bond in the crystalline structure of NIF. The prepared SD improved the NIF dissolution rate in comparison with that of commercial NIF or NIF/HPMC physical mixtures. Moreover, the concentration of NIF in the dissolution medium increased decreasing the NIF content.
AbstractList The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using a suitable dispenser, appears an interesting approach in the treatment of moderate and severe hypertensive emergencies. With this aim nine SD made of NIF and a low viscosity hydroxypropylmethylcellulose (HPMC) in different ratio were prepared by means of spray-drying technique and their structure was studied. Moreover, the drug dissolution properties from SD were verified. The characteristic peaks of crystalline NIF were not detectable by using the X-ray analysis when the NIF/HPMC ratios were lower than 50/50 w/w. In thermograms obtained from SD, the NIF melting endothermic peak disappeared when NIF/HPMC ratios were lower than 30/70 w/w; the experimental Tg values of SD were lower than the Tg values predicted by Gordon Taylor equation suggesting some type of non-ideality of mixing. In the SD FTIR spectra the NH stretching vibrations and the CO stretch in esteric groups of NIF shift to free NH and CO regions indicating the rupture of intermolecular hydrogen bond in the crystalline structure of NIF. The prepared SD improved the NIF dissolution rate in comparison with that of commercial NIF or NIF/HPMC physical mixtures. Moreover, the concentration of NIF in the dissolution medium increased decreasing the NIF content.
The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using a suitable dispenser, appears an interesting approach in the treatment of moderate and severe hypertensive emergencies. With this aim nine SD made of NIF and a low viscosity hydroxypropylmethylcellulose (HPMC) in different ratio were prepared by means of spray-drying technique and their structure was studied. Moreover, the drug dissolution properties from SD were verified. The characteristic peaks of crystalline NIF were not detectable by using the X-ray analysis when the NIF/HPMC ratios were lower than 50/50 w/w. In thermograms obtained from SD, the NIF melting endothermic peak disappeared when NIF/HPMC ratios were lower than 30/70 w/w; the experimental Tg values of SD were lower than the Tg values predicted by Gordon Taylor equation suggesting some type of non-ideality of mixing. In the SD FTIR spectra the NH stretching vibrations and the C=O stretch in esteric groups of NIF shift to free NH and C=O regions indicating the rupture of intermolecular hydrogen bond in the crystalline structure of NIF. The prepared SD improved the NIF dissolution rate in comparison with that of commercial NIF or NIF/HPMC physical mixtures. Moreover, the concentration of NIF in the dissolution medium increased decreasing the NIF content.
Author Montanari, L
Casiraghi, A
Minghetti, P
Cilurzo, F
Author_xml – sequence: 1
  givenname: F
  surname: Cilurzo
  fullname: Cilurzo, F
  email: francesco.cilurzo@unimi.it
– sequence: 2
  givenname: P
  surname: Minghetti
  fullname: Minghetti, P
– sequence: 3
  givenname: A
  surname: Casiraghi
  fullname: Casiraghi, A
– sequence: 4
  givenname: L
  surname: Montanari
  fullname: Montanari, L
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13891090$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12176270$$D View this record in MEDLINE/PubMed
BookMark eNqFkMlKBDEQhoMozqKPoMxF0UNrZemk-yQyuMGAB_Uc0kk1Rnq6x6RH0Kc3s-AcPdUP9dXCNyL7bdciIScUrihQef0CXBVZThW_AHYJkEIm9siQFilwoeQ-Gf4hAzKK8QMAJKP8kAwoo0oyBUMC03cTjO0x-B_T-66ddPWk9TU6v_AtTmLXeDdxPi4wxNSOR-SgNk3E420dk7f7u9fpYzZ7fnia3s4yy0vaZ4ILlkvJubI5d4IjykqWCBXkFVMGqioVbpwpa8ytc5ZJY42wHIRAVuR8TM43exeh-1xi7PXcR4tNY1rsllErWhaqpGUC8w1oQxdjwFovgp-b8K0p6JUqvValVx40ML1WpUWaO90eWFZzdLuprZsEnG0BE61p6mBa6-OO40VJoVxxNxsOk44vj0FH67G1SWFA22vX-X9e-QXUGYa5
CODEN IJPHDE
CitedBy_id crossref_primary_10_1517_17425247_2011_598147
crossref_primary_10_15436_2377_1313_16_020
crossref_primary_10_1016_j_carbpol_2020_115828
crossref_primary_10_3390_macromol3030026
crossref_primary_10_1007_s10973_011_1664_9
crossref_primary_10_1016_j_ijpharm_2012_08_031
crossref_primary_10_3109_03639045_2014_938080
crossref_primary_10_1208_s12249_009_9319_x
crossref_primary_10_1007_s12247_022_09622_4
crossref_primary_10_3109_10837450_2016_1138130
crossref_primary_10_1080_03639045_2018_1503295
crossref_primary_10_1016_j_ijpharm_2012_12_020
crossref_primary_10_1016_j_ijpharm_2015_01_012
crossref_primary_10_1016_j_ijpharm_2022_121471
crossref_primary_10_1016_j_ijpharm_2019_118963
crossref_primary_10_1016_j_biopha_2017_10_161
crossref_primary_10_1016_j_carbpol_2013_08_046
crossref_primary_10_1016_j_jpba_2008_08_031
crossref_primary_10_3109_03639045_2012_685176
crossref_primary_10_18097_pbmc20105602187
crossref_primary_10_1016_j_molstruc_2022_134373
crossref_primary_10_1080_03639040500216097
crossref_primary_10_1080_03639040601179749
crossref_primary_10_1016_j_ijpharm_2005_05_014
crossref_primary_10_1093_jpp_rgab034
crossref_primary_10_1016_j_ijpharm_2020_119768
crossref_primary_10_1016_j_ijpharm_2006_11_029
crossref_primary_10_1016_j_ijpharm_2004_07_042
crossref_primary_10_3109_03639045_2012_692378
crossref_primary_10_1016_j_ijpharm_2005_12_007
crossref_primary_10_1007_s13318_019_00545_z
crossref_primary_10_1021_mp900304p
crossref_primary_10_1002_jps_20925
crossref_primary_10_1016_j_ijpharm_2022_122332
crossref_primary_10_1039_C6CE01645F
crossref_primary_10_3390_ph15080993
crossref_primary_10_1016_j_ijpharm_2003_07_010
crossref_primary_10_1002_jps_10590
Cites_doi 10.1111/j.1742-1241.1986.tb08036.x
10.1021/jm00186a029
10.1248/cpb.46.482
10.1111/j.2042-7158.1994.tb03776.x
ContentType Journal Article
Conference Proceeding
Copyright 2002 Elsevier Science B.V.
2003 INIST-CNRS
Copyright_xml – notice: 2002 Elsevier Science B.V.
– notice: 2003 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/S0378-5173(02)00173-4
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3476
EndPage 317
ExternalDocumentID 10_1016_S0378_5173_02_00173_4
12176270
13891090
S0378517302001734
Genre Journal Article
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29J
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
TEORI
WUQ
ZXP
~02
~G-
AAPBV
ABPIF
ABPTK
IQODW
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
7X8
ID FETCH-LOGICAL-c391t-4342566337c53d43ee6b69e0b05b27a0bbb273ada9fe5cddc26aca4c3044e2853
IEDL.DBID .~1
ISSN 0378-5173
IngestDate Sat Oct 26 00:56:13 EDT 2024
Thu Sep 26 18:49:30 EDT 2024
Sat Sep 28 08:37:32 EDT 2024
Sun Oct 22 16:09:33 EDT 2023
Fri Feb 23 02:34:18 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Solid dispersion
Sublingual administration
Nifedipine
HPMC
Pharmaceutical technology
Control release polymer
Drug carrier
In vitro
Property formulation relationship
Cellulose derivatives
Dosage form
Antihypertensive agent
Active ingredient
Dihydropyridine derivatives
Release
Physicochemical properties
Language English
License CC BY 4.0
LinkModel DirectLink
MeetingName Selected papers from the 13th international symposium on microencapsulation, September 5-7, 2001, Angers, France
MergedId FETCHMERGED-LOGICAL-c391t-4342566337c53d43ee6b69e0b05b27a0bbb273ada9fe5cddc26aca4c3044e2853
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 12176270
PQID 71987919
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_71987919
crossref_primary_10_1016_S0378_5173_02_00173_4
pubmed_primary_12176270
pascalfrancis_primary_13891090
elsevier_sciencedirect_doi_10_1016_S0378_5173_02_00173_4
PublicationCentury 2000
PublicationDate 2002-08-21
PublicationDateYYYYMMDD 2002-08-21
PublicationDate_xml – month: 08
  year: 2002
  text: 2002-08-21
  day: 21
PublicationDecade 2000
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle International journal of pharmaceutics
PublicationTitleAlternate Int J Pharm
PublicationYear 2002
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Suzuki, Sunada (BIB4) 1998; 46
Erbel, Brand, Meyer, Efeert (BIB2) 1983; 59
Triggle, Shefter, Triggle (BIB5) 1980; 23
Abraham, Shukkur, Van Der Meulen, Johny (BIB1) 1986; 40
Save, Shah, Gharmande, Venkitachalam (BIB3) 1994; 46
Save (10.1016/S0378-5173(02)00173-4_BIB3) 1994; 46
Abraham (10.1016/S0378-5173(02)00173-4_BIB1) 1986; 40
Triggle (10.1016/S0378-5173(02)00173-4_BIB5) 1980; 23
Erbel (10.1016/S0378-5173(02)00173-4_BIB2) 1983; 59
Suzuki (10.1016/S0378-5173(02)00173-4_BIB4) 1998; 46
References_xml – volume: 23
  start-page: 1442
  year: 1980
  end-page: 1445
  ident: BIB5
  article-title: Crystal structure of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine
  publication-title: J. Med. Chem.
  contributor:
    fullname: Triggle
– volume: 46
  start-page: 482
  year: 1998
  end-page: 487
  ident: BIB4
  article-title: Influence of water-soluble polymers and the dissolution of nifedipine solid dispersion with combined carriers
  publication-title: Chem. Pharm. Bull.
  contributor:
    fullname: Sunada
– volume: 59
  start-page: 134
  year: 1983
  end-page: 136
  ident: BIB2
  article-title: Emergency treatment of hypertensive crisis with sublingual nifedipine
  publication-title: Med. J.
  contributor:
    fullname: Efeert
– volume: 46
  start-page: 192
  year: 1994
  end-page: 195
  ident: BIB3
  article-title: Comparative study of buccoadesive formulations and sublingual capsules of nifedipine
  publication-title: J. Pharm. Pharmacol.
  contributor:
    fullname: Venkitachalam
– volume: 40
  start-page: 478
  year: 1986
  end-page: 481
  ident: BIB1
  article-title: Sublingual nifedipine—a save and simple therapy for hypertensive emergencies
  publication-title: Br. J. Clin. Pract.
  contributor:
    fullname: Johny
– volume: 40
  start-page: 478
  year: 1986
  ident: 10.1016/S0378-5173(02)00173-4_BIB1
  article-title: Sublingual nifedipine—a save and simple therapy for hypertensive emergencies
  publication-title: Br. J. Clin. Pract.
  doi: 10.1111/j.1742-1241.1986.tb08036.x
  contributor:
    fullname: Abraham
– volume: 23
  start-page: 1442
  year: 1980
  ident: 10.1016/S0378-5173(02)00173-4_BIB5
  article-title: Crystal structure of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00186a029
  contributor:
    fullname: Triggle
– volume: 46
  start-page: 482
  year: 1998
  ident: 10.1016/S0378-5173(02)00173-4_BIB4
  article-title: Influence of water-soluble polymers and the dissolution of nifedipine solid dispersion with combined carriers
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.46.482
  contributor:
    fullname: Suzuki
– volume: 59
  start-page: 134
  issue: Suppl. 3
  year: 1983
  ident: 10.1016/S0378-5173(02)00173-4_BIB2
  article-title: Emergency treatment of hypertensive crisis with sublingual nifedipine
  publication-title: Med. J.
  contributor:
    fullname: Erbel
– volume: 46
  start-page: 192
  year: 1994
  ident: 10.1016/S0378-5173(02)00173-4_BIB3
  article-title: Comparative study of buccoadesive formulations and sublingual capsules of nifedipine
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.1994.tb03776.x
  contributor:
    fullname: Save
SSID ssj0006213
Score 1.9575822
Snippet The sublingual administration of nifedipine (NIF) is currently used in clinical practice. The sublingual administration of NIF solid dispersions (SD), by using...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 313
SubjectTerms Administration, Sublingual
Antihypertensive agents
Biological and medical sciences
Calcium Channel Blockers - chemistry
Cardiovascular system
Crystallography, X-Ray
Differential Thermal Analysis
Excipients
General pharmacology
HPMC
Lactose - analogs & derivatives
Medical sciences
Methylcellulose - analogs & derivatives
Nifedipine
Nifedipine - chemistry
Oxazines
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Solid dispersion
Solubility
Spectroscopy, Fourier Transform Infrared
Sublingual administration
Title Characterization of nifedipine solid dispersions
URI https://dx.doi.org/10.1016/S0378-5173(02)00173-4
https://www.ncbi.nlm.nih.gov/pubmed/12176270
https://search.proquest.com/docview/71987919
Volume 242
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB6kXgQR39ZHzUFEodumyb5ylGKpiiJoobeweSz0si22Hrz4281kty49FMHTQthkwzfZmUky8w3AVYZGgWPME7dug8LDKFBG2CBNVWwVUqB7KqXnl3g4Ch_H0XgD-stcGAyrrHR_qdO9tq5auhWa3dlk0n2j3BeW5xTDghKOnKBItuXWdOe7DvOIWVUi2e2W8O06i6ccwTfeUHbrBwnCdfZpe5bNHWp5We5ivT_q7dJgF3Yqh5LclXPegw1b7MP1a8lI_dUm73WC1bxNrslrzVX9dQC0_0vYXOZjkmlOMNzFYE1rS9zKnBhiJsgnjudq80MYDe7f-8OgKqIQaC56C4TfeTUx54mOuAm5tbGKhaWKRoolGVXKPXhmMpHbSBujWZzpLNSchqFlzpgfQaOYFvYEiEm1G0v3qMjdrtJGKUuU4UYpYSIW5boJnSV0clZyZcg6iMxhLRFrSZn0WMuwCekSYLkidOn0-V9dWysCqT-IF69U0CZcLiUk3R-D1yBZYaefc5ngOYvoiSYcl4Kr-7r9WcwSevr_eZ3Blq8XQ53-6Z1DY_HxaS-c27JQLb8uW7B59_A0fPkBkZvl9w
link.rule.ids 310,311,315,783,787,792,793,4511,23944,23945,24130,25154,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB60HhREfLs-c5Ci0G3TJPvIUYpStRXBFnoLm8dCL22x9eDF326S3bp4KIKnhbDJhm-yM5Nk5huA68wZBepinqixGxTKolBqbsI0lbGRjgLdUyn1X-LukD2NotEadJa5MC6sstT9hU732rpsaZVotmbjcesNU19YnmIXFpRQtg4bzPFn2UXd_KriPGJS1ki22yX3epXGUwzhG28wufWjhGyVgdqeZXMLW17Uu1jtkHrD9LALO6VHie6KSe_BmpnsQ_21oKT-bKBBlWE1b6A6eq3Iqj8PAHd-GJuLhEw0zZGLd9GuqLVBdmmONdJjRyjuDtbmhzB8uB90umFZRSFUlLcXDn_r1sSUJiqimlFjYhlzgyWOJEkyLKV90ExnPDeR0lqROFMZUxQzZoi15kdQm0wn5gSQTpUdS7Uxz-220kQpSaSmWkquIxLlKoDmEjoxK8gyRBVFZrEWDmuBifBYCxZAugRY_JK6sAr9r66XvwRSfdDdvGKOA7haSkjYX8bdg2QTM_2Yi8QdtPA2D-C4EFzV127QYpLg0__P6wo2u4N-T_QeX57PYMsXj8FWGbXPobZ4_zAX1odZyEu_Rr8BHSDnmQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=International+journal+of+pharmaceutics&rft.atitle=Characterization+of+nifedipine+solid+dispersions&rft.au=CILURZO%2C+F&rft.au=MINGHETTI%2C+P&rft.au=CASIRAGHI%2C+A&rft.au=MONTANARI%2C+L&rft.date=2002-08-21&rft.pub=Elsevier&rft.issn=0378-5173&rft.eissn=1873-3476&rft.volume=242&rft.issue=1-2&rft.spage=313&rft.epage=317&rft_id=info:doi/10.1016%2FS0378-5173%2802%2900173-4&rft.externalDBID=n%2Fa&rft.externalDocID=13891090
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon